Meta Pixel

News and Announcements

BPS Technology Announces Exceeding Expectations and Record Revenues

  • Published June 30, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

BPS Technology Limited (“Company”, “BPS” or “BPS Technology”) today announces the following key developments and updates:

KEY TAKEAWAYS:

  • Entertainment Publications (Entertainment) exceeding expectations and on track for record revenues
  • Agreement to onboard BPS’ 17,000 relevant merchants in Australia on to the Alibaba Australia eCommerce platform
  • Commencement of operations in France
  • Significant new agreements entered into by Frequent Values, a division of Entertainment
  • Financial performance and revised earnings before interest, tax, depreciation and amortisation (EBITDA) guidance for FY17

The initiatives above represent further important steps in the evolution of BPS Technology. An overview of these developments, along with updated financial guidance, has been provided below.

More Information

Request Information 

Capital Insights
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be  Attracting Big Pharma’s Attention

Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Join over 45,000+ sophisticated investors

Join Now